Company Filing History:
1 out of 65 
1 out of 23 Years Active: 2020
Title: Myung-Hee Chung: Innovator in Corneal Disease Treatment
Introduction
Myung-Hee Chung is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of corneal diseases. His innovative approach has led to the development of a unique pharmaceutical composition that shows promise in restoring corneal health.
Latest Patents
Chung holds a patent for a pharmaceutical composition containing 8-oxo-deoxyguanosine or a pharmaceutically acceptable salt thereof as an active ingredient for treating corneal disease. This invention is particularly noteworthy as it demonstrates the ability to restore corneal epithelium more quickly and improve corneal clarity when administered to a mouse model of corneal disease induced by ethanol. The findings suggest that 8-oxo-deoxyguanosine may be a valuable treatment option for corneal diseases.
Career Highlights
Throughout his career, Myung-Hee Chung has been associated with reputable institutions such as Gachon University of Industry-Academic Cooperation Foundation and Gil Medical Center. His work in these organizations has allowed him to advance his research and contribute to the medical field significantly.
Collaborations
Chung has collaborated with various professionals in his field, including Dong Hyun Kim, who is a key coworker in his research endeavors.
Conclusion
Myung-Hee Chung's innovative work in developing treatments for corneal diseases highlights his dedication to improving patient outcomes. His contributions to pharmaceutical science are commendable and pave the way for future advancements in this area.